InvestorsHub Logo
Followers 133
Posts 24529
Boards Moderated 2
Alias Born 03/03/2013

Re: Doctor Detroit post# 9395

Monday, 06/06/2016 10:34:50 AM

Monday, June 06, 2016 10:34:50 AM

Post# of 16911
If the FDA is making abuse-deterrant formulations a priority and the HHS is notably aware of this, Probuphine's classification as being the least likely buprenorphine product to be abused, should factor into the equation....

To classify them all the same isn't doing justice to Probuphine's abuse-deterrant technology.



Blessings to All

TRUTH

I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News